FDA reviewers cited limited human clinical evidence and unresolved safety concerns, and the agency will make the final decision
Any decision to incorporate peptide-based therapies is made collaboratively between physician and patient, with a focus on safety, transparency, and evidence-informed care
BPC-157 is often researched for its potential ability to support tissue healing, joint recovery, and inflammation response
That leads to a lot of uncertainty about how you gain access to it, use it, etc
Skin tone and repair processes are improved with these exosomes for a more youthful, resilient appearance
What has changed is the amount of information now available